GMP Human Flt-3 Ligand Protein

DMF
Premium grade (Pre-GMP) version FLL-H5218 is now available for seamless transition.
1/10
+7 View all
製品番号/仕様
価格
Availability
数量
GMP-FLLH28-50ug
$840.00
In Stock - Delivery in 2-3 business days
GMP-FLLH28-1mg (50ug X 20)
$6,425.00
GMP-FLLH28-10mg (50ug X 200)
$44,975.00
GMP-FLLH28
製品金額 :
$ 0
推奨新製品 Request Quote
Contact Us
Contact Us
製品金額:
$ 0
  • 製品詳細
  • データ表示
  • Reviews & Citations
  • Important Statement
  • Resources
Product Details

FLT3L (Fms-related tyrosine kinase 3 ligand)​ is a key cytokine that supports the proliferation, survival, and maintenance of early hematopoietic progenitors and dendritic cells. In HSC expansion systems, FLT3L promotes the self-renewal and output of multipotent progenitors. In iPSC-to-HSC differentiation protocols, it acts in the early hematopoietic specification stage to support the emergence of hemogenic endothelial cells and subsequent hematopoietic progenitor formation.

Product Features and Advantages
  • Specific HSC Expansion Driver​: Efficiently supports hematopoietic stem cell expansion and hPSC-derived hematopoietic stem and progenitor cell differentiation, validated in multiple clinical trials and cell manufacturing processes.
  • Reliable Large-Scale Supply: Ensures batch production capacity, supporting robust and consistent manufacturing scale-up.
  • High Lot-to-Lot Consistency​: Ensures reliable and reproducible performance in every batch, supporting scalable applications.
GMP Platform Advantages
  • Quality Assurance: Global QMS with comprehensive and stringent QC release criteria.
  • End-to-End GMP Compliance: Full manufacturing and QC under a cGMP system.
  • Comprehensive Control of Adventitious Agents: Stringent biosafety from cell banks to final release.
  • Comprehensive Regulatory Support: Includes RSF and DMF to meet global requirements.
  • Resilient Supply Chain: Intelligent modular facilities ensure a stable global supply.
  • Professional Support: Extensive manufacturing and application expertise to accelerate development.
Source

GMP Human Flt-3 Ligand Protein (GMP-FLLH28) is expressed from human 293 cells (HEK293). It contains AA Thr 27 - Pro 185 (Accession # P49771-1).

Molecular Characterization

This protein carries no "tag".

The protein has a calculated MW of 18.0 kDa. The protein migrates as 24 kDa & 27 kDa±3 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

N-terminal Sequence Analysis

Thr-Gln-Asp-Cys-Ser-Phe-Gln-His-Ser-Pro-Ile-Ser-Ser-Asp-Phe
(Routinely tested)

Endotoxin

Less than 10 EU/mg, tested by the LAL method in compliance with USP <85> and Ph. Eur. 2.6.14.

Host Cell Protein

<0.5 ng/µg of protein tested by ELISA.

Host Cell DNA

<0.02 ng/μg of protein tested by qPCR.

Sterility

Sterility testing was performed using the membrane filtration method in compliance with USP <71> and Ph. Eur. 2.6.1.

Mycoplasma

Negative

Purity

>95% as determined by SDS-PAGE.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with protectants.

Contact us for customized product form or formulation.

Vial Specification

2R (13 mm neck finish)

Shipping and Storage

This product is supplied and shipped on blue ice.

Upon receipt, store it immediately at -20°C or lower for long term storage.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 5 years in lyophilized state;
  • -70°C for 12 months under sterile conditions after reconstitution.

バックグランド

FMS-like tyrosine kinase 3 ligand (Flt-3 Ligand) is also known as FL, Flt3L and FLT3LG, is an α-helical cytokine that promotes the differentiation of multiple hematopoietic cell lineages. FLT3LG is expressed as a noncovalentlylinked dimer by T cells and bone marrow and thymic fibroblasts. Each 36 kDa chain carries approximately 12 kDa of N- and O- linked carbohydrates. FLT3LG is structurally homologous to stem cell factor (SCF) and colony stimulating facor 1 (CSF-1). FLT3LG acts as a growth factor that increases the number of immune cells by activating the hematopoietic progenitors. It also induces the mobilization of the hematopoietic progenitors and stem cells in vivo which may help the system to kill cancer cells. FLT3LG induces the expansion of monocytes and immature dendritic cells as well as early B cell lineage differentiation. FLT3LG cooperates with IL2, IL6, IL7, and IL15 to induce NK cell development and with IL3, IL7 and IL11 to induce terminal B cell maturation. Animal studies also show FLT3LG to reduce the severity of experimentally induced allergic inflammation. FLT3LG is crucial for steady-state pDC and cDC development. A lack of FLT3L results in low levels of DCs.